LIBRITABS Drug Patent Profile
Which patents cover Libritabs, and what generic alternatives are available?
Libritabs is a drug marketed by Valeant Pharm Intl and is included in three NDAs.
The generic ingredient in LIBRITABS is chlordiazepoxide. There is one drug master file entry for this compound. Additional details are available on the chlordiazepoxide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LIBRITABS?
- What are the global sales for LIBRITABS?
- What is Average Wholesale Price for LIBRITABS?
Summary for LIBRITABS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Patent Applications: | 4,536 |
| DailyMed Link: | LIBRITABS at DailyMed |
US Patents and Regulatory Information for LIBRITABS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085482-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085481-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085488-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
